Skip to main content
Premium Trial:

Request an Annual Quote

SeqWright Adds 454 GS FLX System to Services Offering

NEW YORK (GenomeWeb News) – SeqWright said today that it has purchased a GS FLX  DNA sequencing system from Roche’s 454 Life Sciences subsidiary.
 
The Houston, Texas-based genomics services provider had previously purchased a SOLiD next-gen sequencer from Applied Biosystems.
 
It said the GS FLX would complement the ABI system and enable it to offer a more diverse array of next-generation services, including de novo sequencing of higher organisms. “For example, utilizing the strengths of the two systems, SeqWright can create a scaffold sequence using the long reads of the GS FLX and subsequently combine that scaffold with the vast amounts of sequence data from SOLiD to build up the genomic coverage,” SeqWright said in a statement.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.